Clinical Trial Update: IL-2 in Refractory Autoimmune Encephalitis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for IL-2 in refractory autoimmune encephalitis across Phase 1 and Phase 2 has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Encephalitis

Drugs mentioned

• IL-2 (Interleukin-2)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Encephalitis | Phase 1, Phase 2 | Status: COMPLETED